Correlation between retinal morphological and functional findings and clinical severity in Parkinson’s disease

Djamgoz MB, Hankins MW, Hirano J, Archer SN (1997) Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res 37(24):3509–3529

Bodis-Wollner I (1990) Visual deficits related to dopamine deficiency in experimental animals and Parkinson’s disease patients. Trends Neurosci 13(7):296–302

Jackson GR, Owsley C (2003) Visual dysfunction, neurodegenerative diseases and aging. Neurol Clin North Am 21:709–728

Price MJ, Feldman RG, Kayne H (1992) Abnormalities in color vision and contrast sensitivity in Parkinson’s disease. Neurology 42:887–890

Bodis-Wollner I, Yahr M (1978) Measurement of visual evoked potentials in Parkinson’s disease. Brain 101:661–671

Harnois C, Di Paolo T (1990) Decreased dopamine in the retinas of patients with Parkinson’s disease. Invest Ophthalmol Vis Sci 31:2473–2475

Bodis-Wollner I, Marx MS, Mitra S, Bobak P, Mylin L, Yahr M (1987) Visual dysfunction in Parkinson’s disease loos in spatiotemporal contrast sensitivity. Brain 110:1675–1698

Dinner DS, Lüders H, Hanson M, Lesser RP, Klem G (1985) Pattern evoked potentials (PEPS) in Parkinson’s disease. Neurology 35:610–613

Nightingale S, Mitchell KW, Howe JW (1986) Visual evoked cortical potentials and pattern electroretinograms in Parkinson’s disease and control subjects. J Neurol Neurosurg Psychiatry 49:1280–1287

Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A (2004) Retinal nerve fiber thinning in Parkinson disease. Vision Res 44:2793–2797

Krivoy D, Gentile R, Liebmann JM, Stegman Z, Rosen R, Walsh JB, Ritch R (1996) Imaging congenital optic disc pit using optical coherence tomography. Arch Ophthalmol 114:165–170

Hee MR, Puliafito CA, Wong C, Duker JS et al (1995) Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol 113:1019–1029

Hee MR, Puliafito CA, Wong C, Duker JS et al (1995) Optical coherence tomography of macular holes. Ophthalmology 102:748–756

Guedes V, Schuman JS, Hertzmark E et al (2003) Optical coherence tomography measurement of macular and nerve fiber layer thickness in normal and glaucomatous human eyes. Ophthalmology 110:177–189

Fahn S (1987) Unified Parkinson’s disease rating scale development comitte and Elton RL, 1987. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Caine D (Eds) Recent developments in Parkinson’s disease. Raven, New York, pp 153–163

Celesia GG, Kauffman D, Cone SB (1986) Simultaneous recording of pattern electroretinography and visual evoked potentials in multiple sclerosis. A method to separate a demyelination from axonal damage to the optic nerve. Arch Neurol 43:1247–1252

Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA (1991) Optical coherence tomography. Science 254:1178–1181

Hee MR, Izatt JA, Swanson EA, Huang D, Schuman JS, Lin CP, Puliafito CA, Fujimoto JG (1995) Optical coherence tomography of the human retina. Arch Ophthalmol 113:325–332

Schuman JS (1997) Optical coherence tomography for imaging and quantification of nerve fiber layer thickness. In: Schuman JS (ed) Imaging in glaucoma, Slack Inc., Thorofare, pp 95–130

Jankovic J, Marsden CD (1988) Therapeutic strategies in Parkinson’s disease. In: Jankovic J, Tolosa E (eds) Parkinson’s disease and movefsment disorders. Urban & Schwarzenberg, Baltimore, pp 95–119

Lang AE, Lozano AM (1998) Parkinson’s disease—first of two parts. New Engl J Med 339(15):1044–1053

Tatton WG, Kwan MM, Verrier MC, Seniuk NA, Theriault E (1990) MPTP produces reversible disappereance of thyrosine hydroxylase containing retinal amacrine cells. Brain Res 527:21–31

Reader TA, Quesney LF (1986) Dopamine in the visual cortex of the cat. Experimentia 42:1242–1244

Parkinson D (1989) Evidence for a dopaminergic innervation of cat primary cortex. Neuroscience 30:171–179

Bodis-Wollner I (2003) Neuropsychological and perceptual defects in Parkinson’s disease. Parkinson’s Dis Relat Disord 9(suppl 2):83–89

Iseri PK, Altintas O, Tokay T, Yuksel N (2006) Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 26(1):18–24

Parisi V, Manni G, Spadaro M, Colacino G, Restuccia R, Marchi S, Bucci MG, Pierelli F (1999) Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 40(11):2520–2527

Parisi V, Pierelli F, Coppola G, Restuccia R, Ferrazzoli D, Scassa C, Bianco F, Parisi L, Fattapposta F (2007) Reduction of optic nerve fiber layer thickness in CADASIL. Eur J Neurol 14(6):627–631

Tagliati M, Bodis-Wollner I, Yahr MD (1996) The pattern electroretinogram in Parkinson’s disease reveals lack of retinal spatial tuning. Electroencephalogr Clin Neurophysiol 100(1):1–11

Peppe A, Stanzione P, Pierantozzi M, Semprini R, Bassi A, Santilli AM, Formisano R, Piccolino M, Bernardi G (1998) Does pattern electroretinogram spatial tuning alteration in Parkinson’s disease depend on motor disturbances or retinal dopaminergic loss? Electroencephalogr Clin Neurophysiol 106(4):374–382

Ghilardi MF, Bodis-Wollner I, Onofrj MC, Marx MS, Glover AA (1988) Spatial frequency-dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model. Brain 111(Pt 1):131–149

Seibyl JP, Marek KL, Quinlan D, Sheff K, Zoghbi S, Zea-Ponce Y, Baldwin RM, Fussell B, Smith EO, Charney DS et al (1995) Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson’s disease. Ann Neurol 38(4):589–598

Brücke T, Asenbaum S, Pirker W, Djamshidian S, Wenger S, Wöber C, Müller C, Podreka I (1997) Measurement of the dopaminergic degeneration in Parkinson’s disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. J Neural Transm Suppl 50:9–24

Varma R, Skaf M, Barron E (1996) Retinal nerve fiber layer thickness in normal human eyes. Ophthalmology 103(12):2114–2119. Erratum in: Ophthalmology 1997 104(2):174

Sihota R, Sony P, Gupta V, Dada T, Singh R (2006) Diagnostic capability of optical coherence tomography in evaluating the degree of glaucomatous retinal nerve fiber damage. Invest Ophthalmol Vis Sci 47(5):2006–2010

Manassakorn A, Nouri-Mahdavi K, Caprioli J (2006) Comparison of retinal nerve fiber layer thickness and optic disk algorithms with optical coherence tomography to detect glaucoma. Am J Ophthalmol 141(1):105–115

Kanamori A, Nakamura M, Escano MF, Seya R, Maeda H, Negi A (2003) Evaluation of the glaucomatous damage on retinal nerve fiber layer thickness measured by optical coherence tomography. Am J Ophthalmol. 135(4):513–520

Zeimer R (1998) Application of the retinal thickness analyzer to the diagnosis and management of ocular diseases. Ophthalmol Clin North Am 11:359–379